Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

Sanofi (SNY)

-NYSE
51.68 Down 0.46(0.88%) Apr 17, 4:02PM EDT
|After Hours : 52.25 Up 0.57 (1.10%) Apr 17, 6:16PM EDT
Add to Portfolio
Prev Close:52.14
Open:51.78
Bid:51.65 x 700
Ask:51.67 x 800
1y Target Est:55.33
Beta:1.1
Next Earnings Date:N/A
Day's Range:51.26 - 51.81
52wk Range:43.57 - 57.42
Volume:914,319
Avg Vol (3m):1,705,700
Market Cap:135.14B
P/E (ttm):29.36
EPS (ttm):1.76
Div & Yield:1.62 (3.20%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNYDown 0.88%135.14B
GSKDown 0.61%113.76B
MRKDown 1.66%161.44B
PFEDown 0.43%214.76B

Key Statistics

Forward P/E (1 yr):16.46
P/S (ttm):3.75
Ex-Dividend Date:06-May-15

Analysts

Annual EPS Est (Dec-15) :3.07
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):2.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, including Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback